Animab Lands EUR 10 Million Series B Funding to Advance Nanoprotec®
Deal News | Jul 01, 2025 | Qbic Venture Partners
Animab, a company specializing in the production of their product Nanoprotec®, has successfully raised EUR 10 million in a Series B financing round. The investment, led by Qbic Venture Partners, is aimed at supporting the commercialization effort of Nanoprotec® within the European market. This funding is seen as a critical step to increase Animab's market presence and scaling operations for its innovative product which is designed to meet specific market needs.
Sectors
- Biotechnology
- Venture Capital
Geography
- Europe – The focus of the funding is to support the commercialization of Animab's product Nanoprotec® within Europe.
Industry
- Biotechnology – Animab operates within the biotechnology sector focusing on innovative products like Nanoprotec®.
- Venture Capital – Qbic Venture Partners is a venture capital firm investing in innovative companies like Animab.
Financials
- EUR 10 Million – The amount secured by Animab in the Series B financing round.
Participants
| Name | Role | Type | Description |
|---|---|---|---|
| Animab | Target Company | Company | Company focused on biotechnology and the production of Nanoprotec®. |
| Qbic Venture Partners | Bidding Company/Buyer | Company | Venture capital firm leading the Series B financing round. |